日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Circulating tumor cells as predictive biomarkers in the risk stratification of DCIS: Evidence of early dissemination

循环肿瘤细胞作为导管原位癌风险分层的预测性生物标志物：早期扩散的证据

期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.adz0187
Nagpal, Neha; Rupp, Brittany; Hong, Yan; Wagner, Jamie; Larson, Kelsey; Balanoff, Christa; Aripoli, Allison; Huppe, Ashley; Winblad, Onalisa; Peterson, Jessica; Hill, Molly; Smith, Camron; Fabian, Carol; Godwin, Andrew K; Fields, Timothy; Wicha, Max; Behbod, Fariba; Nagrath, Sunitha
肿瘤细胞
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control

克服早期乳腺癌预防试验的挑战：巴泽多昔芬和结合雌激素与等待名单对照组的比较

期刊:Contemporary Clinical Trials
影响因子:1.9
doi:10.1016/j.cct.2024.107697
Fabian, Carol J; Mudaranthakam, Dinesh Pal; Gajewski, Byron; Young, Kate; Winblad, Onalisa; Khan, Seema A; Garber, Judy E; Esserman, Laura J; Yee, Lisa D; Nye, Lauren; Powers, Kandy R; Ranallo, Lori; Kreutzjans, Amy L; Pittman, Krystal; Altman, Christy; Metheny, Trina; Zelenchuk, Adrian; Komm, Barry S; Kimler, Bruce F
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2024
文献求助 收藏

NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast Cancer.

NEMO 是雌激素和孕激素的转录靶点，与乳腺癌中的肿瘤抑制因子 PML 有关联

期刊:Cancer Research
影响因子:16.6
doi:10.1158/0008-5472.CAN-16-2794
Elsarraj Hanan S, Valdez Kelli E, Hong Yan, Grimm Sandra L, Ricci Lawrence R, Fan Fang, Tawfik Ossama, May Lisa, Cusick Therese, Inciardi Marc, Redick Mark, Gatewood Jason, Winblad Onalisa, Hilsenbeck Susan, Edwards Dean P, Hagan Christy R, Godwin Andrew K, Fabian Carol, Behbod Fariba
肿瘤
乳腺癌
PML
发表日期：2017
文献求助 收藏